Janus Biotech

Cronologia

Prieteni

Fotografii

Video

Blogs

Adauga Prieteni

Pagini

Grupuri

Events

Căutare

Building a Vonoprazan PCD Franchise Business: A Practical Roadmap for Tier-2 and Tier-3 India

Plenty of articles explain why Vonoprazan is a hot molecule right now. Fewer explain what a franchise partner should actually do with that opportunity once they've decided to pursue it. Knowing that the gastro segment is growing doesn't tell you which territory to pick, how to structure your first six months with prescribing doctors, or when to expect the business to actually turn a profit....

Janus Biotech

2026-08-25 11:29:45

Continua…

Building a Profitable Urology PCD Territory: Matching Your Product Portfolio to What's Actually Being Prescribed

Most guides to urology PCD franchises tell you the market is growing and monopoly rights are good business. Both true, but neither tells you the thing that actually determines whether your territory makes money in year one: whether your product portfolio matches what urologists, general physicians, and nephrologists in your specific area are actually prescribing. "Urology" isn't one market....

Janus Biotech

2026-08-13 11:34:40

Continua…

The Future of Vonoprazan PCD Pharma Business in India: What the Next Few Years Actually Look Like

Every so often, a single molecule reshapes an entire therapy category faster than anyone expects. In Indian gastroenterology, that molecule right now is Vonoprazan. Within a year of wider availability, Vonoprazan-based formulations became the best-selling new drug launch in the Indian Pharmaceutical Market, generating roughly ₹187 crore in sales across more than 400 brands, according to IQVIA's...

Janus Biotech

2026-08-07 10:28:40

Continua…

Vonoprazan HP Kit: Composition, Dosage Schedule & PCD Franchise Investment Guide (2026)

Quick answer: The Vonoprazan HP Kit is a combination therapy for H. pylori eradication that packages Vonoprazan (a potassium-competitive acid blocker) with amoxicillin — and often clarithromycin for triple therapy — plus Domperidone, taken as a coordinated 7-to-14-day course. For a PCD franchise partner, it's structured as a standard monopoly-basis product: a valid drug license, GST...

Janus Biotech

2026-07-30 09:31:10

Continua…

Vonoprazan PCD Franchise in India: Why This Gastro Segment Is Worth a Closer Look in 2026

Gastro complaints are one of the few therapy categories in Indian pharma where demand almost never slows down — heartburn, acid reflux, and H. pylori-related ulcers are common across every season, every income bracket, and nearly every region. That steady baseline demand is exactly why a Vonoprazan PCD franchise has become one of the more talked-about opportunities in the gastro segment...

Janus Biotech

2026-07-08 09:42:17

Continua…

Vonoprazan PCD: A Complete Guide to the Tablet, Dosage, Brands, and Franchise Opportunity in India

Janus Biotech

2026-06-29 06:05:01

Continua…

Vonoprazan 20 mg & 10 mg: PCD and Third-Party Manufacturing

Janus Biotech

2026-06-24 09:06:57

Continua…

How Monopoly Pharma Franchise Companies Solve Business Challenges in 2026

In today's competitive pharmaceutical market, building a profitable business requires more than just quality products. Monopoly pharma franchise companies are helping entrepreneurs, distributors, wholesalers, and healthcare professionals overcome common industry challenges through exclusive territory rights, reliable product supply, strong business support, and quality-assured medicines. A...

Janus Biotech

2026-06-18 11:41:04

Continua…

Orthopaedic Pharma Franchise in India: How to Choose the Best Company, Invest Smart & Build a Profitable Business

Author: Writing team - Janus BiotechCategory: Pharmaceutical Business / Healthcare FranchiseTarget Audience: Pharma entrepreneurs, PCD distributors, medical representatives, franchise investors Why the Orthopaedic Pharma Segment Is Booming in India India's pharmaceutical industry is one of the largest in the world, and within it, the orthopedic segment stands out as one of the fastest-growing...

Janus Biotech

2026-06-08 07:19:47

Continua…

Why Some Pharma Franchise Businesses Fail to Grow Despite India's Expanding Pharma Market

India's pharmaceutical industry is expected to continue growing, with industry estimates projecting revenue growth of around 7–9% in FY26. Yet many pharma franchise businesses struggle to achieve consistent growth, even while demand for medicines continues to rise. Growth Is Not the Same as Market Opportunity One of the biggest misconceptions in the pharma franchise industry is that a...

Janus Biotech

2026-06-03 07:29:35

Continua…

Why Your Pharma Franchise Business Is Not Growing in 2026?

Why is your Pharma Franchise Business not growing in 2026? This infographic by Janus Biotech highlights the most common reasons behind slow pharma franchise growth, including low doctor coverage, weak product portfolios, poor marketing support, high competition, and lack of digital presence. Many PCD pharma franchise businesses struggle because they focus only on product sales while ignoring...

Janus Biotech

2026-06-02 06:31:03

Continua…

Private Label Niacinamide Serum Manufacturers in India: Complete Brand Launch Guide (2026)

Reading time: 10 minutes | Last updated: June 2026 Author: Janus Biotech: Private Label & Contract Manufacturing Specialists, India Who this is for: D2C skincare entrepreneurs, dermatology clinic brands, pharma companies entering cosmeceuticals, beauty influencers launching product lines, and retailers building house-brand serums The Indian face serum market crossed ₹3,500 crore in...

Janus Biotech

2026-06-01 07:09:14

Continua…

Arata mai mult